Avita Medical, Inc. Common Stock (RCEL) is a publicly traded Healthcare sector company. As of October 20, 2026, RCEL trades at $13.87 with a market cap of $406.38M and a P/E ratio of -9.15. RCEL moved +4.68% today. Year to date, RCEL is +297.69%; over the trailing twelve months it is +244.14%. Its 52-week range spans $3.22 to $14.08. Analyst consensus is strong buy with an average price target of $13.67. Rallies surfaces RCEL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for RCEL, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $13.87 |
| Market Cap | $406.38M |
| P/E Ratio | -9.15 |
| EPS | $-1.43 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.08 |
| 52-Week Low | $3.22 |
| Volume | 392.32K |
| Avg Volume | 0 |
| Revenue (TTM) | $75.63M |
| Net Income | $-43.08M |
| Gross Margin | 81.56% |
3 analysts cover RCEL: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.67.